WallStreetZenWallStreetZen

NASDAQ: PHAR
Pharming Group Nv Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Pharming Group Nv earnings were $444.2k for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest PHAR earnings report on Sep 30, 2025 announced Q3 2025 earnings of $8.9M, up 60.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PHAR reported annual earnings of -$12.3M, with 5.2% growth.

PHAR past earnings growth

How has PHAR's earnings growth performed historically?

Company
N/A
Industry
61.5%
Market
54.97%
PHAR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PHAR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PHAR earnings history

Current Revenue
$426.2M
Current Earnings
$449.4k
Current Profit Margin
0.1%

PHAR Return on Equity

Current Company
0.2%
Current Industry
-21.2%
Current Market
35.8%
PHAR's Return on Equity (0.2%)... subscribe to Premium to read more.
High Return on Equity Performance

PHAR undefined

Current Company
0.1%
Current Industry
-8.7%
PHAR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PHAR announces earnings.

PHAR undefined

Current Company
3.9%
Current Industry
-3.4%
PHAR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PHAR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PHAR$35.75M$444.19k-100.00%$0.00
ORIC-$134.07M-$135.27MN/A-$1.73
PVLA-$27.96M-$35.07MN/A-$1.62
OCS-$127.15M-$128.52MN/A-$2.69
GLUE$30.28M$20.95MN/A$0.32
View Top Biotech Stocks

Pharming Group Nv Earnings Reports & History FAQ

What were Pharming Group Nv's earnings last quarter?

On PHAR's earnings call on Invalid Date, Pharming Group Nv (NASDAQ: PHAR) reported Q3 2025 earnings per share (EPS) of $0.13, up 490.91% year over year. Total PHAR earnings for the quarter were $8.88 million. In the same quarter last year, Pharming Group Nv's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Pharming Group Nv stock.

Is Pharming Group Nv profitable or losing money?

As of the last Pharming Group Nv earnings report, Pharming Group Nv is currently profitable. Pharming Group Nv's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $449.41 thousand, a 102.27% decrease year over year.

What was PHAR's earnings growth in the past year?

As of Pharming Group Nv's earnings date in Invalid Date, Pharming Group Nv's earnings has grown year over year. PHAR earnings in the past year totalled $444.19 thousand.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.